Published in J Clin Microbiol on January 13, 2010
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32
Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol (2011) 1.99
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85
What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol (2010) 1.70
Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J Clin Microbiol (2011) 1.62
Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol (2012) 1.54
Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol (2010) 1.49
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn (2011) 1.41
Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study). BMC Med Res Methodol (2010) 1.38
Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease. J Clin Microbiol (2010) 1.38
Comparison of five assays for detection of Clostridium difficile toxin. J Mol Diagn (2011) 1.36
Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. J Clin Microbiol (2012) 1.34
Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J Clin Microbiol (2012) 1.34
Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol (2010) 1.20
Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J Clin Microbiol (2012) 1.19
Mechanical disruption of lysis-resistant bacterial cells by use of a miniature, low-power, disposable device. J Clin Microbiol (2011) 1.09
Laboratory diagnosis of bacterial gastroenteritis. Clin Microbiol Rev (2015) 1.03
Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection. J Clin Microbiol (2012) 1.00
Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc (2012) 0.99
Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 0.96
Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J Clin Microbiol (2012) 0.95
Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica (Cairo) (2014) 0.91
Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency. J Clin Microbiol (2011) 0.91
A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1. Eur J Clin Microbiol Infect Dis (2011) 0.87
Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR. J Clin Microbiol (2014) 0.84
A low complexity rapid molecular method for detection of Clostridium difficile in stool. PLoS One (2014) 0.84
Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J Clin Microbiol (2013) 0.83
Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens. J Clin Microbiol (2013) 0.82
Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clin Infect Dis (2015) 0.81
Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting. Eur J Clin Microbiol Infect Dis (2015) 0.80
Comparison of a frozen human foreskin fibroblast cell assay to an enzyme immunoassay and toxigenic culture for the detection of toxigenic Clostridium difficile. Diagn Microbiol Infect Dis (2012) 0.80
Evaluation of the Qiagen artus C. difficile QS-RGQ Kit for Detection of Clostridium difficile Toxins A and B in Clinical Stool Specimens. J Clin Microbiol (2015) 0.80
Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence. PLoS One (2014) 0.78
Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests. Dig Dis Sci (2012) 0.78
Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay. J Clin Microbiol (2014) 0.77
Evaluation of an automated rapid diagnostic test for detection of Clostridium difficile. PLoS One (2014) 0.76
Evaluation of a chromogenic culture medium for the detection of Clostridium difficile. Yonsei Med J (2014) 0.76
Glutamate dehydrogenase for laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol (2010) 0.76
Evaluation of multiplex PCR with enhanced spore germination for detection of Clostridium difficile from stool samples of the hospitalized patients. Biomed Res Int (2013) 0.76
Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing. Can J Infect Dis Med Microbiol (2013) 0.75
Laboratory Testing of Donors and Stool for Fecal Microbiota Transplantation for Recurrent C. difficile Infection. J Clin Microbiol (2017) 0.75
Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection. J Clin Microbiol (2014) 0.75
The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment. Hawaii J Med Public Health (2017) 0.75
Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile. Infect Dis Ther (2014) 0.75
Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea. PLoS One (2016) 0.75
Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (2017) 0.75
Detection of clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay. Saudi J Gastroenterol (2017) 0.75
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med (2006) 4.64
Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis (2007) 3.24
Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol (2008) 3.21
Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol (2009) 3.18
Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol (2008) 3.15
Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis (2007) 2.90
Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med (1999) 2.87
Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol (2007) 2.77
Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol (2006) 2.72
Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol (2004) 2.09
Measures to control and prevent Clostridium difficile infection. Clin Infect Dis (2008) 2.04
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J Clin Microbiol (2008) 1.88
Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis (1988) 1.86
Does my patient have Clostridium difficile infection? Ann Intern Med (2009) 1.80
Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol (2004) 1.71
The new Clostridium difficile--what does it mean? N Engl J Med (2005) 1.53
Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol (2008) 1.49
Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies. Curr Opin Gastroenterol (2009) 1.38
Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol (2009) 1.34
Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill (2007) 1.24
Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol (2008) 1.21
Recent advances in Clostridium difficile-associated disease. Gut (2008) 1.19
Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect (1999) 1.17
Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill (2006) 1.03
Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection. Clin Vaccine Immunol (2008) 1.03
Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. Eur J Clin Microbiol Infect Dis (1995) 1.01
Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. Euro Surveill (2009) 0.96
[Comparison of two enzyme immunoassay for detection of Clostridium difficile toxin A and toxin B]. Korean J Lab Med (2009) 0.91
[Intestinal colonization and nosocomial spread of Clostridium difficile in pediatric cancer patients under long-term hospitalization]. Kansenshogaku Zasshi (2008) 0.89
[Comparison of Two Enzyme Immunoassays for Clostridium difficile Toxin A.]. Korean J Lab Med (2006) 0.85
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol (2012) 5.46
Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol (2011) 4.37
Scaling up malaria control in Zambia: progress and impact 2005-2008. Am J Trop Med Hyg (2010) 3.81
Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J (2007) 3.80
Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis (2002) 2.80
A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm (2010) 2.73
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol (2013) 2.58
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation. J Cardiovasc Electrophysiol (2012) 2.40
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32
Generation of metal nanoparticles from silver and copper objects: nanoparticle dynamics on surfaces and potential sources of nanoparticles in the environment. ACS Nano (2011) 2.28
A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Heart Rhythm (2011) 2.04
Reductions in artemisinin-based combination therapy consumption after the nationwide scale up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg (2012) 1.99
Plasmodium falciparum parasite infection prevalence from a household survey in Zambia using microscopy and a rapid diagnostic test: implications for monitoring and evaluation. Acta Trop (2009) 1.81
Geographical patterns and predictors of malaria risk in Zambia: Bayesian geostatistical modelling of the 2006 Zambia national malaria indicator survey (ZMIS). Malar J (2010) 1.71
Effect of drugs on defibrillation capacity. Drugs (2008) 1.58
Prediction of significant left main coronary artery stenosis by the 12-lead electrocardiogram in patients with rest angina pectoris and the withholding of clopidogrel therapy. Am J Cardiol (2003) 1.54
Measuring coverage in MNCH: accuracy of measuring diagnosis and treatment of childhood malaria from household surveys in Zambia. PLoS Med (2013) 1.48
New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm (2007) 1.40
Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms. Circ Arrhythm Electrophysiol (2013) 1.40
Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia. Parasit Vectors (2012) 1.38
Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale (2011) 1.38
Systematic evaluation of nanomaterial toxicity: utility of standardized materials and rapid assays. ACS Nano (2011) 1.37
Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation (2005) 1.34
Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles. Comp Biochem Physiol C Toxicol Pharmacol (2011) 1.11
A quasi-experimental evaluation of an interpersonal communication intervention to increase insecticide-treated net use among children in Zambia. Malar J (2012) 1.11
Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol (2003) 1.09
A changing tachycardia that did not change. J Cardiovasc Electrophysiol (2002) 1.06
Evaluation of alternative mosquito sampling methods for malaria vectors in Lowland South--East Zambia. Parasit Vectors (2013) 1.06
Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol (2014) 1.05
Documenting malaria case management coverage in Zambia: a systems effectiveness approach. Malar J (2013) 1.03
Photorhabdus asymbiotica, a pathogen emerging on two continents that proves that there is no substitute for a well-trained clinical microbiologist. J Clin Microbiol (2005) 1.00
Malaria risk: estimating clinical episodes of malaria. Nature (2005) 0.95
Malaria infection and anemia prevalence in Zambia's Luangwa District: an area of near-universal insecticide-treated mosquito net coverage. Am J Trop Med Hyg (2011) 0.95
Association between early childhood exposure to malaria and children's pre-school development: evidence from the Zambia early childhood development project. Malar J (2013) 0.92
Stability of rotors and focal sources for human atrial fibrillation: focal impulse and rotor mapping (FIRM) of AF sources and fibrillatory conduction. J Cardiovasc Electrophysiol (2014) 0.92
Performance of the GeneXpert enterovirus assay for detection of enteroviral RNA in cerebrospinal fluid. J Clin Virol (2008) 0.92
Short-term rapid atrial pacing produces electrical remodeling of sinus node function in humans. J Cardiovasc Electrophysiol (2002) 0.89
Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model. Heart Rhythm (2005) 0.88
Principles of electroanatomic mapping. Indian Pacing Electrophysiol J (2008) 0.87
Automation in the clinical microbiology laboratory. Clin Lab Med (2013) 0.87
The role of the Heart Rhythm Society in integrating the healthcare enterprise. Heart Rhythm (2006) 0.87
Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm (2007) 0.86
Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm (2008) 0.86
Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session. J Am Coll Cardiol (2002) 0.83
Magnetic electroanatomic mapping of an atrial tachycardia requiring ablation within the coronary sinus. J Cardiovasc Electrophysiol (2003) 0.83
Health impact and cost-effectiveness of a private sector bed net distribution: experimental evidence from Zambia. Malar J (2013) 0.82
Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events. Heart Rhythm (2005) 0.82
Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm (2011) 0.81
Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race. Womens Health (Lond Engl) (2008) 0.79
Pacemap of delta wave for successful ablation of traumatized atrioventricular accessory pathway. Heart Rhythm (2012) 0.79
Sensitivity and specificity of a rapid rRNA gene probe assay for simultaneous identification of Staphylococcus aureus and detection of mecA. J Clin Microbiol (2005) 0.78
Identification of gold nanoparticle-resistant mutants of Saccharomyces cerevisiae suggests a role for respiratory metabolism in mediating toxicity. Appl Environ Microbiol (2012) 0.77
Focal mechanism of ventricular tachycardia in coronary artery disease. Heart Rhythm (2009) 0.76
The spectrum of atrial domestication. J Cardiovasc Electrophysiol (2006) 0.75
What is the optimal international normalized ratio for patients undergoing catheter ablation of atrial fibrillation? Pick your poison (dose). Circ Arrhythm Electrophysiol (2013) 0.75
Correction: Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel. PLoS One (2016) 0.75
The precordial thump: convertio cordis, commotio cordis, or neither? Pacing Clin Electrophysiol (2007) 0.75
Catheter ablation of sustained ventricular tachycardia: what's new? J Cardiovasc Electrophysiol (2009) 0.75
Back to basics: the value of simple diagnostic maneuvers in diagnosing supraventricular tachycardias. J Cardiovasc Electrophysiol (2013) 0.75
Pharmacologic targets for atrial fibrillation. Expert Opin Ther Targets (2007) 0.75
Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy. J Clin Microbiol (2013) 0.75
Classification of pre-excited tachycardias by electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace (2012) 0.75
Epicardial-only scar in cardiomyopathy:where the LAVA lurks. J Cardiovasc Electrophysiol (2014) 0.75
The trials and tribulations of fibrillation ablation. J Cardiovasc Electrophysiol (2008) 0.75
Anorexia nervosa and ventricular fibrillation. Clin Pediatr (Phila) (2005) 0.75
Appropriate or inappropriate ICD therapy? Heart Rhythm (2005) 0.75
Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death. Curr Cardiol Rep (2007) 0.75
Ventricular arrhythmias. Preface. Cardiol Clin (2008) 0.75
2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). Circ Arrhythm Electrophysiol (2015) 0.75
Mechanism of transition from irregular to regular supraventricular tachycardia. Pacing Clin Electrophysiol (2005) 0.75
Paradoxical cardiac memory during permanent his bundle pacing. J Cardiovasc Electrophysiol (2014) 0.75
COCATS 4 Task Force 11: Training in Arrhythmia Diagnosis and Management, Cardiac Pacing, and Electrophysiology. J Am Coll Cardiol (2015) 0.75
Infants 1-90 days old hospitalized with human rhinovirus infection. J Clin Lab Anal (2014) 0.75
2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). J Am Coll Cardiol (2015) 0.75